150 Hallucinogens and Drugs of Abuse
• The most common chief complaint when patients have hallucinogenic intoxication is altered mental status.
• Optimal treatment depends on symptom-based (rather than drug-based) diagnostic strategies and interventions.
• An elevated temperature is the most important prognostic sign of poor outcome.
• Most new drugs cannot be identified with hospital-based blood or urine tests, and results of urine drug screens should never be considered diagnostic.
• Treatment for drug-induced hypertension should involve generous doses of benzodiazepines before antihypertensive agents are considered.
• Substance abuse counseling and referral are required for all patients before discharge.
Epidemiology
Recreational abuse of hallucinogens and other drugs is common among patients in the emergency department (ED) and is directly responsible for many ED visits. Although the exact prevalence of drug abuse in patients in the ED is unknown because so much drug abuse goes undetected, various surveillance studies all indicate that ED visits related to drug use continue to rise yearly.1–3
Recreational drug use today knows no demographic, age, or socioeconomic boundaries. Drug use is just as common (although perhaps less frequently suspected) in white, employed, and insured individuals as in patients who are nonwhite, unemployed, or homeless.1,4 In the last 2 decades, first-time drug use has become more common among adolescents, and the variety of drugs used has exploded.5,6 Drug use is no longer limited to what can be identified on a standard hospital toxicology screen, and many of the drugs people abuse to become high are not illegal, such as cough and cold products and prescription medications.7–10 The rampant growth of drug use is likely linked to the proliferation of the Internet and the wide availability of unregulated partisan drug sites that enable potential users to learn about drugs, to order the raw ingredients and supplies to manufacture their own drugs, or simply to purchase drugs online in the safety of their own homes.6
Pathophysiology
Most recreational drugs are highly lipophilic and easily cross the blood-brain barrier, so most result in some euphoria; otherwise, patients would have little reason to abuse them.3 Although the exact mechanisms are still incompletely understood, modulation of central dopaminergic activity, which is responsible for pleasure seeking and reward reinforcement, is an important factor in the euphoric response and the development of drug addiction.3 Recreational drugs also affect, to variable extents, peripheral and central norepinephrine, serotonin (5-HT), N-methyl-D aspartate (NMDA), and GABA activity.
Presenting Signs and Symptoms
The most common presenting feature in all patients with recreational drug use is some degree of altered mental status. It may range from seemingly benign giddiness to life-threatening agitation or obtundation. Drug-associated altered mental status may be associated with any kind of vital sign abnormalities or evidence of end-organ damage. Cardiovascular, neurologic, infectious, and psychiatric complaints are also common (Table 150.1). Because the predominant drugs seen in a particular ED vary depending on local geographic preferences and because the types of drugs abused change far more quickly than published medical literature can keep up with, optimal treatment depends on symptom-based (rather than drug-based) diagnostic strategies and interventions.
SIGN OR SYMPTOM | RESPONSIBLE DRUG(S) |
---|---|
Altered mental status | All |
Agitation | |
Obtundation | |
Hypothermia | |
Hyperthermia | |
Tachycardia | |
Bradycardia | |
Hypertension | |
Hypotension | |
Seizures |
GHB, gamma-hydroxybutyrate; LSD, D-lysergic acid diethylamide; MDMA, methylenedioxymethamphetamine; PCP, phencyclidine.
The following paragraphs discuss some of the more common drugs of abuse historically prevalent in most EDs. Identifying previously undetected drug abuse requires some familiarity with these common drugs and the street slang associated with them (Table 150.2).
Dextromethorphan | |
Gamma-hydroxybutyrate (GHB) | |
Ketamine | |
Methylenedioxymethamphetamine (MDMA) | |
Mephedrone | |
Methamphetamine |
Priority Actions